Diagnostic value of serum B7-H4 for hepatocellular carcinoma

Journal of Surgical Research

Volumn 197, Issue 2, 2015, Pages 301-306

  Zhang, Cheng ^a   Li, Yiming ^b   Wang, Yang ^c  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c Xianyang Central Hospital   (China)

Author keywords

Hepatocellular carcinoma; Prognosis; Soluble B7 H4; Tumor progression

Indexed keywords

V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; TUMOR MARKER; VTCN1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR INVASION; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; EVALUATION STUDY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84930870069     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.04.034     Document Type: Article

References (26)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69
3. Z.Y. Tang Hepatocellular carcinoma surgery - review of the past and prospects for the 21st century J Surg Oncol 91 2005 95
4. P. Greaves, and J.G. Gribben The role of B7 family molecules in hematologic malignancy Blood 121 2013 734
5. D.V. Prasad, S. Richards, X.M. Mai, and C. Dong B7S1, a novel B7 family member that negatively regulates T cell activation Immunity 18 2003 863
6. G.L. Sica, I.H. Choi, and G. Zhu B7-H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 2003 849
7. B. Tringler, S. Zhuo, and G. Pilkington B7-h4 is highly expressed in ductal and lobular breast cancer Clin Cancer Res 11 2005 1842
8. S. Salceda, T. Tang, and M. Kmet The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation Exp Cell Res 306 2005 128
9. L. Cheng, J. Jiang, and R. Gao B7-H4 expression promotes tumorigenesis in ovarian cancer Int J Gynecol Cancer 19 2009 1481
10. L.L. Zhang, S.L. Shao, and Y. Wu Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance Chin J Cancer 29 2010 25
11. Y. Sun, Y. Wang, and J. Zhao B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 2006 143
12. Z.Y. Li, X.H. Zhang, and Y. Chen Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors Onco Targets Ther 6 2013 869
13. Y. Chen, J. Sun, and H. Zhao The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer Onco Targets Ther 7 2014 1465
14. T. Arigami, Y. Uenosono, and M. Hirata Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis J Surg Oncol 102 2010 748
15. T. Arigami, Y. Uenosono, S. Ishigami, T. Hagihara, N. Haraguchi, and S. Natsugoe Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer World J Surg 35 2011 2051
16. M. Fan, Q. Zhuang, and Y. Chen B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma Int J Clin Exp Pathol 7 2014 6768
17. W.H. Liu, Y.Y. Chen, and S.X. Zhu B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms Oncol Lett 8 2014 2527
18. C. He, H. Qiao, H. Jiang, and X. Sun The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival Clin Dev Immunol 2011 2011 695834
19. I. Simon, S. Zhuo, and L. Corral B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer Cancer Res 66 2006 1570
20. I. Simon, Y. Liu, and K.L. Krall Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer Gynecol Oncol 106 2007 112
21. H. Shi, M. Ji, and J. Wu Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer World J Surg Oncol 12 2014 188
22. R.H. Thompson, X. Zang, and C.M. Lohse Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage Cancer Res 68 2008 6054
23. Y. Kamimura, H. Kobori, and J. Piao Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses Biochem Biophys Res Commun 389 2009 349
24. K.C. Mugler, M. Singh, and B. Tringler B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration Appl Immunohistochem Mol Morphol 15 2007 363
25. D. Quandt, E. Fiedler, D. Boettcher, W. Marsch, and B. Seliger B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response Clin Cancer Res 17 2011 3100
26. D. Dangaj, E. Lanitis, and A. Zhao Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses Cancer Res 73 2013 4820